SHC

SHC

USD

Sotera Health Company Common Stock

$11.260-0.120 (-1.054%)

실시간 가격

Healthcare
Diagnostics & Research
미국

가격 차트

핵심 지표

시장 지표
기업 기본 정보
거래 통계

시장 지표

시가

$11.380

고가

$11.435

저가

$11.160

거래량

0.16M

기업 기본 정보

시가총액

3.2B

산업

Diagnostics & Research

국가

United States

거래 통계

평균 거래량

1.26M

거래소

NMS

통화

USD

52주 범위

저가 $9.53현재가 $11.260고가 $17.08

AI 분석 리포트

마지막 업데이트: 2025년 4월 27일
AI 생성데이터 소스: Yahoo Finance, Bloomberg, SEC

SHC: Sotera Health Company Common Stock - Analyzing Recent Moves & What Might Come Next

Stock Symbol: SHC Generate Date: 2025-04-27 03:51:17

Let's break down what's been happening with Sotera Health (SHC) based on the latest information. We'll look at the news headlines, how the stock price has been acting, and what some predictions are saying.

Recent News Buzz: Analysts Trim Expectations

The news flow for SHC lately seems a bit cautious, mainly centered around analyst views.

  • Just a few days ago, Piper Sandler kept their "Neutral" rating on the stock but decided to lower their price target from $15 down to $13.
  • A bit earlier in April, Barclays also maintained a positive-leaning "Overweight" rating, which sounds good, but they also cut their price target, dropping it from $16 to $12.
  • There was also news about the date for the first-quarter 2025 earnings release. This is just an announcement, not really positive or negative in itself, but it means investors will soon get a clearer picture of the company's financial health.

So, the main takeaway from the analyst news is that while some still see potential (Barclays' "Overweight"), they are becoming less optimistic about how high the stock might go in the near term, lowering those price targets. That's a signal of tempered expectations.

Price Check: A Rough Ride, Then a Small Bounce

Looking at the stock's movement over the past few months tells a story of decline.

  • Back in late January and February, the stock was trading comfortably in the $13 to $14 range.
  • Things took a noticeable turn for the worse around late February and early March, with the price dropping sharply.
  • The slide continued into April, hitting a 52-week low of $9.53 on April 9th. That was quite a drop from where it started the year.
  • However, since hitting that low, the stock has seen a bit of a bounce, trading recently in the $10 to $11 range. The last price we have is around $11.15 (as of April 25th).

Comparing this to the AI's prediction for the next few days, it forecasts a slight dip, predicting negative percentage changes. This suggests the recent bounce might face some pressure soon, potentially pushing the price down a bit from the current level.

Outlook & Ideas: Navigating Mixed Signals

Putting the pieces together – analysts lowering targets, a significant price drop followed by a small bounce, and a near-term AI prediction for a dip – paints a picture that calls for caution right now.

  • The Apparent Near-Term Leaning: The signals are somewhat mixed, but the analyst target cuts and the AI's prediction for the next few days lean towards a cautious or slightly negative outlook in the immediate future. The recent bounce is positive, but it's happening against a backdrop of lowered expectations and predicted near-term weakness. It seems like a "wait and see" situation might be prudent.
  • Potential Entry Consideration: Given the AI predicts a dip and analysts have trimmed targets, jumping in right now might be risky. If someone were considering buying, waiting to see if the predicted dip happens, or waiting for more clarity after the upcoming earnings report, could be a more patient approach. The technical recommendation data from a couple of days ago did suggest entry points around $11.05-$11.12 based on bullish technicals at that time, but the AI's forward-looking prediction for today and tomorrow suggests the price might move away from those levels downwards.
  • Potential Exit/Stop-Loss Consideration: For those already holding the stock, managing risk is key. The technical recommendation data suggested a stop-loss level around $10.60. This is below the last trading price and could serve as a point to consider exiting if the price starts to fall significantly, helping to limit potential losses. Taking profits might be considered if the recent bounce continues unexpectedly, but the AI prediction makes this less likely in the very short term.

Company Context: What SHC Does

Remember, Sotera Health is in the healthcare sector, providing essential sterilization and lab testing services. This is a critical, albeit sometimes complex, part of the healthcare supply chain. The company's fundamentals, like its high debt and high P/E ratio mentioned in the data, are factors that investors often consider alongside price movements and news. These fundamental points might explain some of the caution analysts are showing, despite the essential nature of the business.


Disclaimer: This analysis is based solely on the provided data and is for informational purposes only. It is not financial advice. Stock markets are volatile, and prices can move unexpectedly. You should always conduct your own thorough research and consider consulting with a qualified financial advisor before making any investment decisions.

관련 뉴스

Analyst Upgrades

Piper Sandler Maintains Neutral on Sotera Health, Lowers Price Target to $13

Piper Sandler analyst Jason Bednar maintains Sotera Health with a Neutral and lowers the price target from $15 to $13.

더 보기
Piper Sandler Maintains Neutral on Sotera Health, Lowers Price Target to $13
GlobeNewswire

Sotera Health Announces First-Quarter 2025 Earnings Release Date

CLEVELAND, April 17, 2025 (GLOBE NEWSWIRE) -- Sotera Health Company (NASDAQ:SHC), a leading global provider of mission-critical end-to-end sterilization solutions and lab testing and advisory services for the

더 보기
Sotera Health Announces First-Quarter 2025 Earnings Release Date
Analyst Upgrades

Barclays Maintains Overweight on Sotera Health, Lowers Price Target to $12

Barclays analyst Luke Sergott maintains Sotera Health with a Overweight and lowers the price target from $16 to $12.

더 보기
Barclays Maintains Overweight on Sotera Health, Lowers Price Target to $12

AI 예측Beta

AI 추천

약세

업데이트 시간: 2025년 4월 28일 오후 09:26

약세중립강세

63.5% 신뢰도

리스크 & 트레이딩

리스크 수준4/5
고위험
적합 대상
공격적
트레이딩 가이드

진입점

$11.05

익절

$11.38

손절

$10.60

핵심 요소

PDI 11.1이(가) ADX 10.5과 함께 MDI 6.0 위에 있어 강세 추세를 시사합니다.
현재 가격이 지지선($11.08)에 매우 근접하여 강력한 매수 기회를 시사합니다.
거래량은 평균(14,120)의 9.8배로 극도로 강력한 매수 압력을 나타냅니다.
MACD -0.0008이(가) 신호선 -0.0051 위에 있어 강세 교차를 나타냅니다.

최신 정보 받기

가격 알림 설정, AI 분석 업데이트 및 실시간 시장 뉴스 받기